Glenmark Pharmaceuticals Ltd. | Cash Flow
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,969
5,943
10,047
12,602
-
Depreciation, Depletion & Amortization
2,168
2,600
2,635
5,765
-
Funds from Operations
9,562
5,722
7,810
13,542
11,284
Changes in Working Capital
2,901
2,673
6,077
8,615
-
Net Operating Cash Flow
6,661
3,049
1,733
4,927
-
Capital Expenditures
3,766
5,443
8,903
7,485
-
Sale of Fixed Assets & Businesses
39
63
16
151
-
Purchase/Sale of Investments
20
44
-
-
-
Net Investing Cash Flow
3,748
5,833
8,887
7,334
-
Cash Dividends Paid - Total
632
635
679
678
-
Issuance/Reduction of Debt, Net
2,046
4,807
110
7,943
-
Net Financing Cash Flow
963
4,193
8,786
7,267
-
Net Change in Cash
1,896
311
934
1,971
-
Free Cash Flow
2,895
2,394
7,170
2,558
-
Net Assets from Acquisitions
-
409
-
-
-
Change in Capital Stock
125
20
9,355
3
-
Exchange Rate Effect
1,980
1,719
699
2,890
-
About Glenmark Pharmaceuticals
View Profile
